All‐In‐One Dendrimer‐Based Lipid Nanoparticles Enable Precise HDR‐Mediated Gene Editing In Vivo
- 17 June 2021
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 33 (30) , 2006619-e2006619
Abstract
Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR‐associated (Cas) protein gene editing is poised to transform the treatment of genetic diseases. However, limited progress has been made toward precise editing of DNA via homology‐directed repair (HDR) that requires careful orchestration of complex steps. Herein, dendrimer‐based lipid nanoparticles (dLNPs) are engineered to co‐encapsulate and deliver multiple components for in vivo HDR correction. BFP/GFP switchable HEK293 cells with a single Y66H amino acid mutation are employed to assess HDR‐mediated gene editing following simultaneous, one‐pot delivery of Cas9 mRNA, single‐guide RNA, and donor DNA. Molar ratios of individual LNP components and weight ratios of the three nucleic acids are systematically optimized to increase HDR efficiency. Using flow cytometry, fluorescence imaging, and DNA sequencing to quantify editing, optimized 4A3‐SC8 dLNPs edit >91% of all cells with 56% HDR efficiency in vitro and >20% HDR efficiency in xenograft tumors in vivo. Due to the all‐in‐one simplicity and high efficacy, the developed dLNPs offer a promising route toward the gene correction of disease‐causing mutations.Keywords
Funding Information
- National Institutes of Health
- National Institute of Biomedical Imaging and Bioengineering (R01 EB025192‐01A1)
- Cystic Fibrosis Foundation (SIEGWA18XX0)
- Cancer Prevention and Research Institute of Texas (RP190251, RP160157)
- American Cancer Society (RSG‐17‐012‐01)
- National Institutes of Health
- National Cancer Institute (P30CA142543)
- National Institutes of Health
- National Institute of Biomedical Imaging and Bioengineering (R01 EB025192‐01A1)
- Cystic Fibrosis Foundation (SIEGWA18XX0)
- Cancer Prevention and Research Institute of Texas (RP190251, RP160157)
- American Cancer Society (RSG‐17‐012‐01)
- Welch Foundation (I‐1855)
- National Cancer Institute (P30CA142543)
This publication has 70 references indexed in Scilit:
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteriaProceedings of the National Academy of Sciences, 2012
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase IIINature, 2011
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNANature, 2010
- Short motif sequences determine the targets of the prokaryotic CRISPR defence systemMicrobiology, 2009
- Lipid-based Nanoparticles for Nucleic Acid DeliveryPharmaceutical Research, 2007
- On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acidsGene Therapy, 2001
- Characterization of Lipid DNA Interactions. I. Destabilization of Bound Lipids and DNA DissociationBiophysical Journal, 1998